Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-06 Sale |
2024-06-11 3:34 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
2,189 | $0.876 | $1,918 | 295,035 (Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 09:49 am |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
25,800 | $0.8784 | $22,663 | 297,224 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-27 6:08 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
38,293 | $1.4397 | $55,129 | 300,594 (Direct) |
View |
| 2023-12-21 Purchase |
2023-12-26 4:08 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Volker Christopher Chief Operating Officer |
75,000 | $1.4 | $105,000 | 75,000 (Direct) |
View |
| 2023-12-21 Sale |
2023-12-26 4:01 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
11,707 | $1.4 | $16,390 | 338,887 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-30 Tax Withholding |
2024-07-02 11:00 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
343 | $0.8 | 294,692 (Direct) |
View |
| 2024-05-31 Tax Withholding |
2024-06-04 11:48 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $0.9299 | 176,157 (Direct) |
View |
| 2024-05-31 Tax Withholding |
2024-06-04 11:39 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $0.9299 | 323,024 (Direct) |
View |
| 2024-05-31 Tax Withholding |
2024-06-04 11:24 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $0.9299 | 1,160,358 (Direct) |
View |
| 2024-04-30 Tax Withholding |
2024-05-02 09:06 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.13 | 176,409 (Direct) |
View |
| 2024-04-30 Tax Withholding |
2024-05-02 08:57 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.13 | 323,114 (Direct) |
View |
| 2024-04-30 Tax Withholding |
2024-05-02 08:49 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.13 | 1,162,597 (Direct) |
View |
| 2024-04-21 Tax Withholding |
2024-04-23 10:21 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
7,250 | $1.15 | 176,661 (Direct) |
View |
| 2024-04-21 Tax Withholding |
2024-04-23 10:09 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
2,030 | $1.15 | 323,204 (Direct) |
View |
| 2024-04-21 Tax Withholding |
2024-04-23 09:53 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
19,673 | $1.15 | 1,164,836 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 11:52 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.2 | 183,911 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 11:45 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.2 | 325,234 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 11:34 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.2 | 1,184,509 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-04 2:10 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.21 | 184,163 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-04 2:01 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.21 | 1,186,748 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-04 1:50 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.21 | 325,324 (Direct) |
View |
| 2024-02-18 Option Award |
2024-02-21 11:08 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
101,743 | $0 | 184,415 (Direct) |
View |
| 2024-02-18 Option Award |
2024-02-21 10:57 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
113,717 | $0 | 244,117 (Direct) |
View |
| 2024-02-18 Option Award |
2024-02-21 10:44 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
25,000 | $0 | 325,414 (Direct) |
View |
| 2024-02-18 Option Award |
2024-02-21 10:14 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
663,497 | $0 | 1,188,987 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-01 1:51 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.25 | 82,672 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-01 1:41 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.25 | 300,414 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-01 1:29 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.25 | 525,490 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-03 1:30 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.58 | 82,924 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-03 1:29 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.58 | 300,504 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-03 1:29 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.58 | 527,729 (Direct) |
View |
| 2023-11-30 Tax Withholding |
2023-12-04 4:32 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.45 | 83,176 (Direct) |
View |
| 2023-11-30 Tax Withholding |
2023-12-04 4:24 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.45 | 350,594 (Direct) |
View |
| 2023-11-30 Tax Withholding |
2023-12-04 4:09 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.45 | 529,968 (Direct) |
View |
| 2023-11-10 Option Award |
2023-11-14 5:30 pm |
N/A 2033-11-09 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Volker Christopher Chief Operating Officer |
324,560 | $0 | 324,560 (Direct) |
View |
| 2023-11-09 Option Award |
2023-11-13 6:03 pm |
N/A 2033-11-08 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
81,067 | $0 | 81,067 (Direct) |
View |
| 2023-11-09 Option Award |
2023-11-13 5:53 pm |
N/A 2033-11-08 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
89,283 | $0 | 89,283 (Direct) |
View |
| 2023-11-09 Option Award |
2023-11-13 5:43 pm |
N/A 2033-11-08 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
17,688 | $0 | 17,688 (Direct) |
View |
| 2023-11-09 Option Award |
2023-11-13 5:30 pm |
N/A 2033-11-08 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
526,303 | $0 | 526,303 (Direct) |
View |